Last reviewed · How we verify
International Study of Inflammation in COVID-19 (ISIC)
This is a prospective multi-center observational study which purpose is to evaluate the ability of blood-based inflammatory markers to risk-stratify patients hospitalized for Covid-19. Blood-based biomarkers examined include: soluble urokinase plasminogen activator receptor (suPAR), C-reactive protein (CRP), procalcitonin, D-dimer, ferritin, lactate dehydrogenase and interleukin-6.
Details
| Lead sponsor | University of Michigan |
|---|---|
| Status | COMPLETED |
| Enrolment | 4463 |
| Start date | Sat Feb 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Thu Dec 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Covid19
- Outcome, Fatal
- Respiratory Failure
- Acute Kidney Injury
- Inflammation
Interventions
- SuPAR, C-reactive protein, Ferritin, D-Dimer, Procalcitonin, Interleukin-6, Lactate Dehydrogenase
Countries
United States